Page last updated: 2024-09-04

canertinib and Adenocarcinoma, Basal Cell

canertinib has been researched along with Adenocarcinoma, Basal Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P1

Other Studies

1 other study(ies) available for canertinib and Adenocarcinoma, Basal Cell

ArticleYear
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured

2006